Skip to main content
Accelerating Clinical Trials in the EU

Governance

The ACT EU Steering Group, established in March 2022, is composed of members from the European Commission, European Medicines Agency (EMA), Heads of Medicines Agencies (HMA), and the Network Portfolio Advisory Group (NPAG). The chair is provided by the European Commission.

The Steering Group has a decision-making role. It oversees the programme management structure, monitors and coordinates activities and deliverables, signs off communications, and recommends solutions in case of critical issues. The Steering Group reports to the EMA Management Board and HMA.

Chair

Sylvain Giraud          

European Commission, Directorate-General for Health and Food Safety (DG SANTE)                      

Members

Peter Arlett

European Medicines Agency (EMA), Head of Data Analytics and Methods Task Force

Karl Broich

Head of Federal Institute For Drugs And Medical Devices (BfArM), Germany

Harald Enzmann

Federal Institute For Drugs And Medical Devices (BfArM), Germany

Chair of the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP)

Björn Eriksson

Head of Medical Products Agency (MPA), Sweden

Heads of Medicines Agencies' Clinical Trials Coordination Group mentor

Antonio López Navas

Agency of Medicines and Medical Products (AEMPS), Spain

Marianne Lunzer

Chair of the Heads of Medicines Agencies' Clinical Trials Coordination Group

Lorraine Nolan

Health Products Regulatory Authority, Chair of the European Medicines Agency's Management Board

Iordanis Gravanis

European Medicines Agency (EMA), Head of Scientific Advice Office

Stan van Belkum

Central Committee on Research Involving Human Subjects (CCMO), Netherlands